These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 22907807

  • 1. Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: a systematic review.
    Moossdorff-Steinhauser HF, Berghmans B.
    Neurourol Urodyn; 2013 Mar; 32(3):206-14. PubMed ID: 22907807
    [Abstract] [Full Text] [Related]

  • 2. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.
    Rai BP, Cody JD, Alhasso A, Stewart L.
    Cochrane Database Syst Rev; 2012 Dec 12; 12(12):CD003193. PubMed ID: 23235594
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial.
    Preyer O, Umek W, Laml T, Bjelic-Radisic V, Gabriel B, Mittlboeck M, Hanzal E.
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug 12; 191():51-6. PubMed ID: 26073262
    [Abstract] [Full Text] [Related]

  • 4. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.
    Peters KM, Macdiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, Siegel SW, Tate SB, Jarnagin BK, Rosenblatt PL, Feagins BA.
    J Urol; 2009 Sep 12; 182(3):1055-61. PubMed ID: 19616802
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis.
    Burton C, Sajja A, Latthe PM.
    Neurourol Urodyn; 2012 Nov 12; 31(8):1206-16. PubMed ID: 22581511
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of percutaneous tibial nerve stimulation versus extended release tolterodine for overactive bladder.
    Chen HW, Bercik RS, Werner EF, Thung SF.
    J Urol; 2012 Jan 12; 187(1):178-84. PubMed ID: 22100006
    [Abstract] [Full Text] [Related]

  • 8. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M, Crampton J.
    Physiotherapy; 2019 Dec 12; 105(4):469-475. PubMed ID: 30862384
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neuromodulative treatment with percutaneous tibial nerve stimulation for intractable detrusor instability: outcomes following a shortened 6-week protocol.
    Yoong W, Ridout AE, Damodaram M, Dadswell R.
    BJU Int; 2010 Dec 12; 106(11):1673-6. PubMed ID: 20590544
    [Abstract] [Full Text] [Related]

  • 14. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG, Al-Buheissi S.
    BJU Int; 2009 Apr 12; 103(7):931-7. PubMed ID: 19281469
    [Abstract] [Full Text] [Related]

  • 15. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results.
    Canbaz Kabay S, Kabay S, Mestan E, Cetiner M, Ayas S, Sevim M, Ozden H, Karaman HO.
    Neurourol Urodyn; 2017 Jan 12; 36(1):104-110. PubMed ID: 26352904
    [Abstract] [Full Text] [Related]

  • 16. Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis.
    Alomari MS, Abdulhamid AS, Ghaddaf AA, Alshareef KM, Haneef AK, AlQuhaibi MS, Banjar RA.
    Int J Urol; 2022 Oct 12; 29(10):1170-1180. PubMed ID: 35711082
    [Abstract] [Full Text] [Related]

  • 17. Percutaneous Tibial Nerve Stimulation Therapy for Overactive Bladder Syndrome: Clinical Effectiveness, Urodynamic, and Durability Evaluation.
    Del Río-Gonzalez S, Aragon IM, Castillo E, Milla-España F, Galacho A, Machuca J, Lara MF, Herrera-Imbroda B.
    Urology; 2017 Oct 12; 108():52-58. PubMed ID: 28687483
    [Abstract] [Full Text] [Related]

  • 18. Different electrode positioning for transcutaneous electrical nerve stimulation in the treatment of urgency in women: a study protocol for a randomized controlled clinical trial.
    Padilha JF, Avila MA, Seidel EJ, Driusso P.
    Trials; 2020 Feb 11; 21(1):166. PubMed ID: 32046754
    [Abstract] [Full Text] [Related]

  • 19. Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women.
    Zimmern P, Litman HJ, Mueller E, Norton P, Goode P, Urinary Incontinence Treatment Network.
    BJU Int; 2010 Jun 11; 105(12):1680-5. PubMed ID: 19912207
    [Abstract] [Full Text] [Related]

  • 20. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
    Kabay S, Canbaz Kabay S, Cetiner M, Mestan E, Sevim M, Ayas S, Ozden H, Ozisik Karaman H.
    Urology; 2016 Jan 11; 87():76-81. PubMed ID: 26436213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.